Literature DB >> 19466991

Comparison of inhibitors of superoxide generation in vascular smooth muscle cells.

Z Luo1, Y Chen, S Chen, W J Welch, B T Andresen, P A Jose, C S Wilcox.   

Abstract

BACKGROUND AND
PURPOSE: We compared the dose-dependent reductions in cellular superoxide anion (O(2)(-)) by catalytic agents: superoxide dismutase (SOD), polyethylene glycol (PEG)-SOD and the nitroxide 4-hydroxy-2,2,6,6,-tetramethylpiperidine-1-oxyl (tempol) with uncharacterized antioxidants: 5,10,15,20-tetrakis (4-sulphonatophenyl) porphyrinate iron (III)(Fe-TTPS), (-)-cis-3,3',4',5,7-pentahydroxyflavane (2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol (-epicatechin), 2-phenyl-1,2-benzisoselenazol-3(2H)-one (ebselen) and N-acetyl-L-cysteine (NAC) with the spin trap nitroblue tetrazolium (NBT) and with the vitamins or their analogues: ascorbate, alpha-tocopherol and 6-hydroxy-2,5,7,8-tetramethylkroman-2-carboxy acid (trolox). EXPERIMENTAL APPROACH: O(2)(-) was generated in primary cultures of angiotensin II-stimulated preglomerular vascular smooth muscle cells from spontaneously hypertensive rats and detected by lucigenin-enhanced chemiluminescence. KEY
RESULTS: SOD, PEG-SOD, NAC and tempol produced a similar maximum inhibition of O(2)(-) of 80-90%. -Epicatechin, NBT, ebselen and Fe-TTPS were significantly (P < 0.0125) less effective (50-70%), whereas trolox, alpha-tocopherol and ascorbate had little action even over 24 h of incubation (<31%). Effectiveness in disrupted and intact cells was similar for the permeable agents, PEG-SOD and tempol, but was enhanced for SOD. Generation of O(2)(-) was increased by NAC and NBT at low concentrations but reduced at high concentrations. CONCLUSIONS AND IMPLICATIONS: Maximum effectiveness against cellular production of O(2)(-) requires cell membrane permeability and catalytic action as exemplified by PEG-SOD or tempol. NAC and NBT have biphasic effects on O(2)(-) production. Vitamins C and E or analogues have low efficacy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466991      PMCID: PMC2737652          DOI: 10.1111/j.1476-5381.2009.00259.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Reversible inhibition of mammalian glutamine synthetase by tyrosine nitration.

Authors:  Boris Görg; Natalia Qvartskhava; Peter Voss; Tilman Grune; Dieter Häussinger; Freimut Schliess
Journal:  FEBS Lett       Date:  2006-12-12       Impact factor: 4.124

2.  Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta.

Authors:  Ezequiel Alvarez; Manuel Campos-Toimil; Hélène Justiniano-Basaran; Claire Lugnier; Francisco Orallo
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

3.  Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells.

Authors:  A K Bhunia; H Han; A Snowden; S Chatterjee
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

4.  Acute antihypertensive action of nitroxides in the spontaneously hypertensive rat.

Authors:  Kinjal Patel; Yifan Chen; Kathryn Dennehy; Jonathan Blau; Stephanie Connors; Margarida Mendonca; Margaret Tarpey; Murali Krishna; James B Mitchell; William J Welch; Christopher S Wilcox
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-09-22       Impact factor: 3.619

5.  Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems.

Authors:  Y Li; H Zhu; P Kuppusamy; V Roubaud; J L Zweier; M A Trush
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

Review 6.  Antioxidants and atherosclerotic heart disease.

Authors:  M N Diaz; B Frei; J A Vita; J F Keaney
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

7.  Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.

Authors:  Montserrat C Cruzado; Norma R Risler; Roberto M Miatello; Guoying Yao; Ernesto L Schiffrin; Rhian M Touyz
Journal:  Am J Hypertens       Date:  2005-01       Impact factor: 2.689

8.  Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs.

Authors:  N Weissmann; F Grimminger; R Voswinckel; J Conzen; W Seeger
Journal:  Am J Physiol       Date:  1998-05

9.  Superoxide dismutase and catalase conjugated to polyethylene glycol increases endothelial enzyme activity and oxidant resistance.

Authors:  J S Beckman; R L Minor; C W White; J E Repine; G M Rosen; B A Freeman
Journal:  J Biol Chem       Date:  1988-05-15       Impact factor: 5.157

10.  Oral pretreatment with ebselen enhances heat shock protein 72 expression and reduces myocardial infarct size.

Authors:  Erdenechimeg Baljinnyam; Naoyuki Hasebe; Masahiko Morihira; Kazuhiro Sumitomo; Tomoyuki Matsusaka; Takayuki Fujino; Jun Fukuzawa; Fumitaka Ushikubi; Kenjiro Kikuchi
Journal:  Hypertens Res       Date:  2006-11       Impact factor: 3.872

View more
  19 in total

1.  Folate receptor-targeted antioxidant therapy ameliorates renal ischemia-reperfusion injury.

Authors:  Sarah F Knight; Kousik Kundu; Giji Joseph; Sergey Dikalov; Daiana Weiss; Niren Murthy; W Robert Taylor
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

2.  cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage.

Authors:  María Castejón-Griñán; Cecilia Herraiz; Conchi Olivares; Celia Jiménez-Cervantes; Jose Carlos García-Borrón
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

Review 3.  Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.

Authors:  Christopher S Wilcox
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

4.  Impaired endothelial function and microvascular asymmetrical dimethylarginine in angiotensin II-infused rats: effects of tempol.

Authors:  Dan Wang; Zaiming Luo; Xiaoyan Wang; Pedro A Jose; John R Falck; William J Welch; Shakil Aslam; Tom Teerlink; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-09-13       Impact factor: 10.190

5.  Thromboxane prostanoid receptors enhance contractions, endothelin-1, and oxidative stress in microvessels from mice with chronic kidney disease.

Authors:  Cheng Wang; Zaiming Luo; Donald Kohan; Anton Wellstein; Pedro A Jose; William J Welch; Christopher S Wilcox; Dan Wang
Journal:  Hypertension       Date:  2015-03-02       Impact factor: 10.190

6.  Inward remodeling of resistance arteries requires reactive oxygen species-dependent activation of matrix metalloproteinases.

Authors:  Luis A Martinez-Lemus; Guiling Zhao; Edgar L Galiñanes; Matthew Boone
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-01       Impact factor: 4.733

Review 7.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

8.  Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells.

Authors:  Zaiming Luo; Tom Teerlink; Kathy Griendling; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-08-09       Impact factor: 10.190

Review 9.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

10.  Experimental evidence for the therapeutic potential of tempol in the treatment of acute liver injury.

Authors:  Mekky M Abouzied; Heba M Eltahir; Ashraf Taye; Mahran S Abdelrahman
Journal:  Mol Cell Biochem       Date:  2015-10-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.